Cập nhật lần cuối :
19/11/2024
đội nghiên cứu - Henri Mondor University Hospital, Department of Pharmacy   Pdf  
Pháp
bệnh viện
Henri Mondor University Hospital, Department of Pharmacy
Créteil
Tài liệu tham khảo   Tài liệu tham khảo   (31)  
1
Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags.
Vieillard V, Paul M (victoire.vieillard@aphp.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2023 -
2
Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C.
Vieillard V, Le Guyader G, Jallades A, Astier A. (victoire.vieillard@aphp.fr)
J Oncol Pharm Practice - 2023 -
3
Etude de stabilité de solutions de pembrolizumab à 1 et 4 mg/mL à 5 et 25°C dans des poches de NaCl 0,9% en polyoléfine .
Avrillon K, Le Guyader G, Doillet H, Jaskowiec C, Paul M, Poullain S. ()
SFPO Congress - 2023 -
5
Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations.
Secretan P-H, Thirion O, Sadou Yayé H, Damy T, Astier A, Paul M, Do B. (phsecretan@yahoo.fr)
Pharmaceuticals - 2021 - ;14, 1242.
6
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
Le Guyader G, Vieillard V, Paul M. (leguyader.guillaume@gmail.com)
J Oncol Pharm Practice - 2020 -
7
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion.
Le Guyader G, Vieillard V, Mouraud S, Do B, Marabelle A, Paul M. (leguyader.guillaume@gmail.com)
Eur J Cancer - 2020 - ; 135: 192-202.
9
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.
Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M. (leguyader.guillaume@gmail.com)
EJHP - 2018 -
10
Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag.
Vieillard V, Paul M, Ibrahim T, Astier A. (victoire.vieillard@aphp.fr)
Ann Pharm Fr - 2017 - ; 75, 6: 420-435.
11
Stabilité physico-chimique de solutions de Nivolumab à 1 mois.
Vieillard V, Bardo P, Akrout W, Le Guyader G, Astier A, Paul M. ()
SFPO Congress 2017 - Nantes - 2017 -
12
Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M. (pascale.bardo@gmail.com)
Eur J Cancer - 2016 - ; 58: 8-16.
13
One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C.
Vieillard V, Astier A, Sauzay C, Paul M. (victoire.vieillard@aphp.fr)
Ann Pharm Fr - 2016 - ; 75, 1 : 17-29.
14
Long-term physico-chemical stability of diluted trastuzumab.
Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A. (prof.astier@gmail.com)
Int J Pharm - 2013 - ; 448: 101-104.
15
Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes
d?Hayer B, Vieillard V, Astier A, Paul M (prof.astier@gmail.com)
Pharmaceut Anal Acta - 2013 - ; 4: 205
16
Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois.
Bardo P, Vieillard V, Astier A, Paul M. (prof.astier@gmail.com)
SFPO Congress, Mandelieu, France - 2013 -
17
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. (prof.astier@gmail.com)
Ann Pharm Fr - 2013 - ; 71, 5: 358-363.
18
Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C.
Vieillard V, da Silva R, Astier A, Paul M. (prof.astier@gmail.com)
ECOP Congress, Budapest, Hungary - 2012 -
19
Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration.
Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A. (prof.astier@gmail.com)
Ann Pharm Fr - 2012 - ; 70, 3: 139-154.
20
Long-term stability of diluted solutions of the monoclonal antibody rituximab.
Paul M, Vieillard V, Jaccoulet E, Astier A. (muriel.paul@hmn.aphp.fr)
Int J Pharm - 2012 - ; 436, 1-2: 282-290.
21
Stabilité physicochimique du bevacizumab 5 mg/mL dilué dans le chlorure de benzalkonium 0.1 mg/mL.
Moine M, Vieillard V, Astier A, Paul M. (prof.astier@gmail.com)
ECOP Congress, Budapest, Hungary - 2012 -
22
Stability of diluted L-asparaginase in normal saline solution.
Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M. (prof.astier@gmail.com)
ECCO Congress Stockholm - 2011 -
23
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M. (prof.astier@gmail.com)
SFPO Congress Mandelieu, France - 2011 -
24
Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène.
Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M. (prof.astier@gmail.com)
SFPO Congress, France - 2011 -
25
Stabilité d'un anticorps monoclonal d'intérêt thérapeutique après reconstitution: le rituximab.
Jaccoulet E, Guirao S, Morand K, Astier A, Paul M. (prof.astier@gmail.com)
SFPO Congress - 2009 -
26
Stabilité de solutions diluées de bévacizumab en fonction de la température.
Morand K, Paul M, Lahlou A, Blanchet B, Astier A. (prof.astier@gmail.com)
SFPO Congress - 2009 -
27
Stabilité de l'infliximab en solutions diluées.
Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. ()
APHIF Congress - 2009 -
28
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
Paul M, Razzouq N, Tixier G, Astier A. (prof.astier@gmail.com)
EJHP Science - 2005 - ; 2: 31-36.
29
Sodium nitroprusside stability at 1 µg/ml in aqueous solutions.
Kaisserlian CE, Razzouq N, Astier A, Paul M. (prof.astier@gmail.com)
EJHP Science - 2005 - ; 11, 4: 88-90.
30
Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution.
Naud C, Marti B, Fernandez C, Astier A, Paul M. ()
Am J Health-Syst Pharm - 1998 - ; 55: 1161-1164.
31
Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité.
Zazempa V, Morgenszejn J, Paul M, Astier A. (prof.astier@gmail.com)
Act Pharm Biol Clin - 1995 - ; 8: 525-528.

Danh sách các chất   phân tử nghiên cứu   (20)  
Thuốc giãn mạch Dạng tiêm Adenosin
Thuốc giãn mạch Dạng tiêm Alprostadil
thuốc trị ung thư Dạng tiêm Asparaginase
thuốc trị ung thư Dạng tiêm Azacitidine
thuốc trị ung thư Dạng tiêm Bevacizumab
thuốc trị ung thư Thuốc nhỏ mắt Bevacizumab
thuốc trị ung thư Dạng tiêm Cetuximab
Khác Dung dịch uống Epigallocatechin gallate
Thuốc kháng virus Dạng tiêm Ganciclovir sodium
Thuốc ức chế miễn dịch Dạng tiêm Infliximab
thuốc trị ung thư Dạng tiêm Ipilimumab
Thuốc giảm đau Dạng tiêm Morphine hydrochloride
Thuốc giãn mạch Dạng tiêm Nitroprusside sodium
thuốc trị ung thư Dạng tiêm Nivolumab
Thuốc giãn mạch Dạng tiêm Papaverine hydrochloride
thuốc trị ung thư Dạng tiêm Pembrolizumab
thuốc trị ung thư Dạng tiêm Rituximab
Thuốc ức chế miễn dịch Dạng bôi da Sirolimus
thuốc trị ung thư Dạng tiêm Trastuzumab
Thuốc hạ huyết áp Dạng tiêm Urapidil

  Mentions Légales